Type 1 diabetes, an autoimmune disease characterized by a loss of insulin-producing beta cells is the focus of The Sanford Project.
To Identify Targets for Treatment of Insulin Resistance and Diabetes Sanford-Burnham Collaborates With Pfizer
Sanford-Burnham Medical Research Institute (Sanford-Burnham) announced that it has entered into a collaboration with Pfizer Inc.
Sanford-Burnham Medical Research Institute (Sanford-Burnham) announced that it has entered into a collaboration with Pfizer Inc.
‘The Sanford Project has enrolled its first patient for conducting the clinical trial on a cell therapy using regulatory T cells, or Treg cells to treat type 1 diabetes.
’
Investigators in this trial are studying the effectiveness of cell therapy with expanded regulatory T cells, or Treg cells, to treat type 1 diabetes. Treg cells regulate the body's immune system. A participant's own Treg cells are extracted from the body, purified and multiplied and returned to blood circulation. Researchers are monitoring if beta cells and insulin production can be preserved through this type of immunotherapy. "The enrollment of the first patient in The Sanford Project: T-Rex Study demonstrates Sanford''s commitment to bringing cutting-edge research and next generation treatments to our region." said Kurt Griffin, director of clinical trials for The Sanford Project. "Leveraging the body's own natural mechanisms is a particularly appealing approach."
Participants in The Sanford Project: T-Rex Study must be 12 to 17 years old and have been diagnosed with diabetes in approximately the last two months.
Diabetes is the No. 1 Reason for Kidney Damage: Health Experts
Ninety percent of people in developing countries consider diabetes to be a trivial disease, which can be controlled throughout their lives on insulin dose.
Ninety percent of people in developing countries consider diabetes to be a trivial disease, which can be controlled throughout their lives on insulin dose.
Source-Newswise
Ixmyelocel-T Therapy Shows Promise Against End-Stage Heart Failure
End-stage heart failure is a condition where the heart fails to pump enough blood. A heart pumping machine is usually given to patients as a temporary measure.
End-stage heart failure is a condition where the heart fails to pump enough blood. A heart pumping machine is usually given to patients as a temporary measure.
California-Based Company to Roll Out World�s First Stem Cell Therapy On Parkinson�s Disease
The company has received approval for conducting a clinical trial of stem cell therapy in patients affected with mild to severe Parkinson’s disease.
The company has received approval for conducting a clinical trial of stem cell therapy in patients affected with mild to severe Parkinson’s disease.
